Prospective Bladder Cancer Infrastructure (ProBCI)
Prospective nation-wide cohort of high-risk non-muscle-invasive, muscle-invasive and metastatic bladder cancer in the Netherlands
Bladder Cancer
Overall survival, Alive/death/emigrated, 10 years
Progression-free survival, Progression/no progression, 10 yeas|Recurrence-free survival, Recurrence/no recurrence, 10 yeas|Health-related quality of life, EQ-5D (EuroQol-Five Dimensions), 2 years|Cancer-specific health-related quality of life, QLQ-C30 (Quality of Life Questionnaire-Cancer), 2 years
Prospective nation-wide cohort of high-risk non-muscle-invasive, muscle-invasive and metastatic bladder cancer in the Netherlands